2021
DOI: 10.1080/19336896.2021.1991771
|View full text |Cite
|
Sign up to set email alerts
|

The role of microglia in prion diseases and possible therapeutic targets: a literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 67 publications
0
7
0
Order By: Relevance
“…M1 phenotype microglia produce a large number of proinflammatory cytokines, including nitric oxide (NO), reactive oxidative species, TNF-α, IL-1β, IL-6, IFN-γ [38], during which the expression of the M1 marker CD16 and iNOS are upregulated. M2 phenotype microglia produce anti-inflammatory factors such as IL-4 and IL-10, during which the expression of the M2 marker CD206, TGF-β, and the metabolic or Arg-1 are upregulated [39–42]. In this study, the microglia marker Iba-1 and the M1 marker iNOS were colabelled in lumbar SDH, and their expression was significantly increased in LDH rats, while expression of the proinflammatory cytokines TNF-α was also increased but significantly decreased after electroacupuncture treatment.…”
Section: Discussionmentioning
confidence: 66%
See 1 more Smart Citation
“…M1 phenotype microglia produce a large number of proinflammatory cytokines, including nitric oxide (NO), reactive oxidative species, TNF-α, IL-1β, IL-6, IFN-γ [38], during which the expression of the M1 marker CD16 and iNOS are upregulated. M2 phenotype microglia produce anti-inflammatory factors such as IL-4 and IL-10, during which the expression of the M2 marker CD206, TGF-β, and the metabolic or Arg-1 are upregulated [39–42]. In this study, the microglia marker Iba-1 and the M1 marker iNOS were colabelled in lumbar SDH, and their expression was significantly increased in LDH rats, while expression of the proinflammatory cytokines TNF-α was also increased but significantly decreased after electroacupuncture treatment.…”
Section: Discussionmentioning
confidence: 66%
“…M1 phenotype microglia produce a large number of proinflammatory cytokines, including nitric oxide (NO), reactive oxidative species, TNF-α, IL-1β, IL-6, IFN-γ [38], during which the expression of the M1 marker CD16 and iNOS are upregulated. M2 phenotype microglia produce anti-inflammatory factors such as IL-4 and IL-10, during which the expression of the M2 marker CD206, TGFβ, and the metabolic or Arg-1 are upregulated [39][40][41][42].…”
Section: Discussionmentioning
confidence: 99%
“…Microglia made up the largest population of cells (99,756/147,536 = 67%) assigned in our library and are well described as particularly responsive to prion replication, taking on reactive phenotypes that can both exacerbate pathology through excess inflammatory signaling and can protect against disease through clearance of toxic PrP Sc [ 53 , 58 , 63 ]. As expected, altered microglial transcripts were involved in cytokine signaling, phagocytosis and microglial activation (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Specific genes such as Il12b , Serpine1 , Jun , Ftl1 , Nav2 , Cd14 , Trim30a and Cd74 demarked some of the microglial subtypes—possibly serving as markers of functionally diverse microglial subsets. Therefore, the next steps will be to verify these microglial sub-populations throughout disease progression and to determine their relative contribution to the reported protective and detrimental properties of activated microglia during prion disease [ 53 , 58 , 63 ].…”
Section: Discussionmentioning
confidence: 99%
“…3a) to maximize production of inflammatory modulators. MSCs change phenotype of microglia from the activated and inflammatory M1 phenotype to the neuroprotective M2 phenotype 33,54,55 www.nature.com/scientificreports/ increased M1 markers 23,25,39 , although the role of M1 and M2 microglia has only begun to be elucidated in prion pathogenesis 23,47,56 .…”
Section: Discussionmentioning
confidence: 99%